Find out how the AOA and its members are improving Americans' access to eye and vision care.

Do you know what your patients are searching for?

An analysis of search terms related to certain eye care reveals what patients are looking for: education. They want to know about treatments.

How doctors of optometry can prevent traumatic brain injuries and make a difference for patients

Does the Medicare population of older U.S. adults underutilize comprehensive eye exams as a prevention strategy against sustaining traumatic brain injuries from falls? The AOA Health Policy Institute suggests the answer is yes.

Doctors rebound from COVID-19 limitations, settle into ‘new normal’

Results of a second AOA Health Policy Institute survey on the pandemic’s impact on optometry show practices are better off now than in April but still nowhere near pre-COVID-19 levels.

Rogue hand sanitizers toxic, may cause methanol poisoning

What’s the rub with your hand sanitizer? The FDA warns health care providers that some products labeled to contain ethanol have tested positive for methanol.

Spread Optometry's Message

Doctors of optometry provide more than two-thirds of primary eye care in the U.S. Let your community know you are trained to examine, diagnose, treat and manage ocular disorders, diseases and injuries and systemic diseases that manifest in the eye.
New cigarette labels graphically depict smoking, cataracts link

Starting in 2021, cigarette packaging and ads will include graphic warnings depicting smoking’s health consequences, including the blinding condition that the AOA emphasized in FDA comments.

U.S. declares public health emergency—what you need to know

COVID-19 may cause ocular signs and symptoms, including photophobia, irritation and ocular discharge.

Excessive device use alters prekindergartners’ white brain matter

Screen time matters when it comes to developing brain and language skills in young children. Educate parents on device use effects on development.

FDA clears contact lens to slow myopia progression

The first-ever contact lens to receive FDA approval for slowing myopia progression could enter the market as soon as 2020.

FDA says fluorescein, ophthalmic meds among drug shortages

An FDA report on drug shortages examines the underlying factors for supply issues as several common ophthalmic drugs currently adorn the list, including fluorescein and glaucoma meds.

Bad flu season on the way? CDC urges early vaccines

Seasonal predictors show concerning trends for the 2019-20 influenza season. Is your office encouraging flu shots?